Letters sent to healthcare professionals in December 2017

Letters were sent about cladribine (Litak and Leustat), radium-223-dichloride (Xofigo▼), and ERWINASE.

In December 2017, the following letters were sent to relevant healthcare professionals:

Article citation: Drug Safety Update volume 11 issue 6; January 2018: 6.

Published 9 January 2018